栓塞保护方式与入路类型对颈动脉支架置入术结局的影响
基于血管质量倡议数据库2016年9月至2024年8月99,030例颈动脉支架置入术患者,采用倾向评分逆概率加权比较经颈动脉血运重建联合血流逆转(TCAR)与其他入路及栓塞保护方式。TCAR似乎是最安全的血管内颈动脉血运重建方式,术后卒中或死亡风险较低。
要点
- 与TCAR相比,经股动脉颈动脉支架置入联合远端栓塞保护(TFCAS-DEP)的院内死亡和30天死亡 odds 均超过两倍。
- 与TCAR相比,经颈动脉颈动脉支架置入联合远端栓塞保护(TCAS-DEP)的30天死亡风险为两倍、卒中风险增加58%。
- 与TCAR相比,经股动脉颈动脉支架置入联合近端球囊阻断血流停止(TFCAS-PBO)的院内死亡和30天死亡 odds 均升高。
核心结论
- 在这项比较颈动脉入路类型和栓塞保护方式的大型多机构研究中,TCAR似乎是最安全的血管内颈动脉血运重建手术,因其术后卒中或死亡风险较低。
- 该研究证实,避免主动脉弓和血流逆转神经保护对于减少颈动脉支架置入术后并发症均很重要。
研究设计与样本
- 在血管质量倡议数据库中识别2016年9月至2024年8月期间所有接受颈动脉支架置入术的患者。
- 使用基于倾向评分的逆概率治疗加权比较TFCAS-DEP、TFCAS-PBO和TCAS-DEP与TCAR的结局,队列按27个基线变量进行加权。
主要发现
- 共纳入99,030例患者:TCAR 66,655例(67.3%);TFCAS-DEP 30,723例(31.0%);TCAS-DEP 912例(0.9%);TFCAS-PBO 740例(0.8%)。
- 与TCAR相比,TFCAS-DEP的院内死亡和30天死亡 odds 均超过两倍(OR 2.68,95%CI 2.25-3.19,P<.001;OR 2.39,95%CI 2.08-2.74,P<.001),卒中/死亡 odds 高62%(OR 1.62,95%CI 1.45-1.81,P<.001)。
- TCAS-DEP组30天死亡风险为两倍(OR 2.00,95%CI 1.13-3.53,P=.016),卒中风险增加58%(OR 1.58,95%CI 1.04-2.38,P=.031)。
- 与TCAR相比,TFCAS-PBO组的院内死亡和30天死亡 odds 均升高(分别为OR 2.47,95%CI 1.22-5.00,P=.012;OR 1.85,95%CI 1.03-3.30,P=.038)。
临床怎么用
- 作者认为,TCAR似乎是最安全的血管内颈动脉血运重建手术,因其术后卒中或死亡风险较低。
- 作者认为,避免主动脉弓和血流逆转神经保护对于减少颈动脉支架置入术后并发症均很重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Carotid artery stenting (CAS) is commonly performed through transfemoral or transcarotid access. Neurologic protection methods utilized during the procedure include distal embolic protection (DEP) and flow reversal devices. Multiple studies demonstrated more favorable outcomes associated with transcarotid artery revascularization with flow reversal (TCAR) in comparison to transfemoral carotid artery stenting with DEP (TFCAS-DEP). However, not many studies compared TCAR with transcarotid artery stenting with DEP (TCAS-DEP) or TFCAS with flow arrest by proximal balloon occlusion (TFCAS-PBO). We aimed to compare the effect of access types and embolic protection methods on the outcomes of CAS. METHODS: All patients undergoing CAS between September 2016 and August 2024 were identified in the Vascular Quality Initiative database. Inverse probability of treatment weighting based on propensity scores was used to compare outcomes of TFCAS-DEP, TFCAS-PBO, and TCAS-DEP with TCAR. Cohorts were weighted with regards to 27 baseline variables. RESULTS: A total of 99,030 patients were included in our study: TCAR, 66,655 (67.3%); TFCAS-DEP, 30,723 (31.0%); TCAS-DEP, 912 (0.9%); and TFCAS-PBO, 740 (0.8%). Compared with TCAR, TFCAS-DEP had more than double the odds of in-hospital and 30-day mortality (odds ratio [OR], 2.68; 95% confidence interval [CI], 2.25-3.19; P < .001; OR, 2.39; 95% CI, 2.08-2.74; P < .001), and 62% higher odds of stroke/death (OR, 1.62; 95% CI, 1.45-1.81; P < .001). The TCAS-DEP group had double the risk of 30-day mortality (OR, 2.00; 95% CI, 1.13-3.53; P = .016) and 58% increased risk of stroke (OR, 1.58; 95% CI, 1.04-2.38; P = .031). Finally, higher odds of in-hospital and 30-day mortality (OR, 2.47; 95% CI, 1.22-5.00; P = .012; and OR, 1.85; 95% CI, 1.03-3.30; P = .038, respectively) were observed in the TFCAS-PBO group when compared with TCAR. CONCLUSIONS: In this large, comprehensive multi-institutional study comparing carotid access types and embolic protection methods, TCAR seems to be the safest endovascular carotid revascularization procedure owing to its lower risk of postoperative stroke or death. This study confirms that avoidance of the aortic arch and flow reversal neuroprotection are both important in reducing complications following CAS.
引用
- Hamouda M, Kang Sim DE, Vootukuru NR, et al. Impact of embolic protection methods versus access types on outcomes of carotid artery stenting. J Vasc Surg. 2025. PMID: 40024379. doi:10.1016/j.jvs.2025.02.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。